Literature DB >> 26823765

C/EBPα inhibits proliferation of breast cancer cells via a novel pathway of miR-134/CREB.

Jianxiang Zhang1, Yanmei Ma2, Shoujun Wang3, Fu Chen4, Yuanting Gu1.   

Abstract

C/EBPα plays an important role in the modulation of cell proliferation, differentiation or apoptosis in various tissues. Most recently, reduced expression of C/EBPα and growth inhibitory effect was found in primary mammary carcinomas. However, the underlying mechanism is still not fully aware. Here, we firstly identified miR-134 as a target of C/EBPα in MCF7 breast cancer cell lines. C/EBPα overexpression promoted miR-134 expression, causing suppression of apoptosis- protective genes CREB and Bcl-2, and resulted in the proliferation inhibition of MCF7 cells. Moreover, anti-miR-134 rescued the proliferation inhibition of MCF7 cells and the suppression of anti-apoptotic genes CREB and Bcl-2 caused by C/EBPα overexpression. Collectively, C/EBPα inhibited cell growth in breast cancer cells via a novel pathway miR-134/CREB.

Entities:  

Keywords:  C/EBPα; CREB; breast cancer cell; miR-134; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26823765      PMCID: PMC4713551     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Heat stress stimulates hepcidin mRNA expression and C/EBPα protein expression in aged rodent liver.

Authors:  Steven A Bloomer; Kevin C Kregel; Kyle E Brown
Journal:  Arch Gerontol Geriatr       Date:  2013-08-08       Impact factor: 3.250

2.  AMPK Plays a Dual Role in Regulation of CREB/BDNF Pathway in Mouse Primary Hippocampal Cells.

Authors:  Weidong Huang; Jie Cao; Xiaobin Liu; Facai Meng; Min Li; Bo Chen; Jie Zhang
Journal:  J Mol Neurosci       Date:  2015-02-03       Impact factor: 3.444

3.  Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.

Authors:  Sigal Gery; Sakae Tanosaki; Shikha Bose; Namrata Bose; Jay Vadgama; H Phillip Koeffler
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

4.  MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.

Authors:  Kazuhiro Kitamura; Masahiro Seike; Tetsuya Okano; Kuniko Matsuda; Akihiko Miyanaga; Hideaki Mizutani; Rintaro Noro; Yuji Minegishi; Kaoru Kubota; Akihiko Gemma
Journal:  Mol Cancer Ther       Date:  2013-11-20       Impact factor: 6.261

Review 5.  Role of microRNAs in maintaining cancer stem cells.

Authors:  Michela Garofalo; Carlo M Croce
Journal:  Adv Drug Deliv Rev       Date:  2014-11-20       Impact factor: 15.470

6.  Suv39h1 mediates AP-2α-dependent inhibition of C/EBPα expression during adipogenesis.

Authors:  Zhi-Chun Zhang; Yuan Liu; Shu-Fen Li; Liang Guo; Yue Zhao; Shu-Wen Qian; Bo Wen; Qi-Qun Tang; Xi Li
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

7.  The landscape of cancer genes and mutational processes in breast cancer.

Authors:  Philip J Stephens; Patrick S Tarpey; Helen Davies; Peter Van Loo; Chris Greenman; David C Wedge; Serena Nik-Zainal; Sancha Martin; Ignacio Varela; Graham R Bignell; Lucy R Yates; Elli Papaemmanuil; David Beare; Adam Butler; Angela Cheverton; John Gamble; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; King Wai Lau; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Keiran Raine; Roland Rad; Michael Spencer Chapman; Jon Teague; Douglas Easton; Anita Langerød; Ming Ta Michael Lee; Chen-Yang Shen; Benita Tan Kiat Tee; Bernice Wong Huimin; Annegien Broeks; Ana Cristina Vargas; Gulisa Turashvili; John Martens; Aquila Fatima; Penelope Miron; Suet-Feung Chin; Gilles Thomas; Sandrine Boyault; Odette Mariani; Sunil R Lakhani; Marc van de Vijver; Laura van 't Veer; John Foekens; Christine Desmedt; Christos Sotiriou; Andrew Tutt; Carlos Caldas; Jorge S Reis-Filho; Samuel A J R Aparicio; Anne Vincent Salomon; Anne-Lise Børresen-Dale; Andrea L Richardson; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

8.  The CaMK4/CREB/IRS-2 cascade stimulates proliferation and inhibits apoptosis of β-cells.

Authors:  Bo Liu; Helena Barbosa-Sampaio; Peter M Jones; Shanta J Persaud; Dany S Muller
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.

Authors:  Luciano Cascione; Pierluigi Gasparini; Francesca Lovat; Stefania Carasi; Alfredo Pulvirenti; Alfredo Ferro; Hansjuerg Alder; Gang He; Andrea Vecchione; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease.

Authors:  Farhoud Faraji; Ying Hu; Gang Wu; Natalie E Goldberger; Renard C Walker; Jinghui Zhang; Kent W Hunter
Journal:  Genome Res       Date:  2013-12-09       Impact factor: 9.043

View more
  4 in total

Review 1.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.

Authors:  Yan Guo; Yuji Ma; Xuanhao Hu; Rongbo Song; Li Zhu; Ming Zhong
Journal:  Cancer Biol Ther       Date:  2018-01-15       Impact factor: 4.742

3.  SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines.

Authors:  Tsu-Yang Chao; Theresa Kordaß; Wolfram Osen; Stefan B Eichmüller
Journal:  Mol Cell Biochem       Date:  2022-07-02       Impact factor: 3.396

4.  CREB1, a direct target of miR-122, promotes cell proliferation and invasion in bladder cancer.

Authors:  Lihua Guo; Min Yin; Yixuan Wang
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.